Michelle O’Brien, DO, received her medical degree from Western University of Health Sciences, Oregon in 2015 and completed one year of internal medicine at The Wright Center in Scranton, Pennsylvania before transitioning to psychiatry. She received her undergraduate degree in biology from Grinnell College, Iowa in 2011. Interested in medicine for quite some time, she was initially drawn to med/psych and continues to thrive on a holistic approach to health care. Her interests in psychiatry are varied and include addiction, forensics and inpatient or outpatient adult. In her spare time she enjoys running, hiking, star gazing and playing with her dogs. Michelle recently graduated from the University of Arizona Psychiatry Residency Program.
Jamie Weinand, MD, obtained his medical degree from Boston University School of Medicine in 2017. He received his B.S. in biology and a B.A. in spanish from Duke University in 2012. Following his undergraduate graduation, Jamie completed a Fulbright scholarship in Mexico City in 2013. His professional interests include addiction medicine and Lesbian, Gay, Bisexual and Transgender (LGBT) healthcare. A native of Tucson, Arizona, Jamie graduated from Salpointe Catholic High School in 2008 and is thrilled to be back home. Outside of work he enjoys hiking, learning languages and reading. Jamie recently graduated from the Southern New Mexico Family Medicine Residency Program.
The expansion of the University of Arizona Addiction Medicine Program has coincided when relapse from addiction is at an all-time high during the COVID-19 pandemic. Nevertheless, the available resources to Banner – University Medical Center (BUMC) patients over the last year has expanded to meet the needs of our community regarding substance use disorders. Key initiatives of this year have been the implementation of a fellow physician Addiction Medicine clinic, the BUMC Main and South Campus Addiction Medicine Consult service and expansion of medication assisted treatment options at BUMC including buprenorphine-naloxone. In preparation for this expansion of addiction medicine services, a quality improvement project was developed to identify the initial knowledge base, perceptions and self-reported barriers among residents and attending physicians regarding buprenorphine-naloxone prescribing.
- Identify knowledge base among residents and attending physicians regarding buprenorphine-naloxone prescribing.
- Describe perceptions among residents and attending physicians of barriers to implementing buprenorphine-naloxone prescribing.
- Discuss resources for University of Arizona addiction services including buprenorphine-naloxone inductions.
To register your attendance for CME credit, at the beginning of the presentation, please text 691321 to 866-327-3062.
All faculty, CME Planning Committee members, and the CME office reviewer have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.
The University of Arizona College of Medicine – Tucson is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.